Enrichment of mRNA and Bisulfite-mRNA Library Preparation for Next-Generation Sequencing
July 7th, 2023
This protocol provides an easy-to-follow workflow to conduct poly(A) RNA purification, bisulfite conversion, and library preparation using standardized equipment for a biological sample of interest.
This research aims to study the role of RNA methylation, specifically 5-methylcytosine modification, in pancreatic cancer. The questions we want to answer are how upregulation or downregulation of certain RNA methyltransferase affects cancer cell phenotypes and also, through which RNA substrates. This study provides the comprehensive RNA m5C landscape at a single-base resolution with standardized equipment.
From this study using bisulfite RNA seq, the results links the association of RNA m5C modification with poor differentiation of cancer cells. This should pave the way for future studies in discerning passenger versus disease driver effects of specific m5C in the RNA transcripts. With this technique, we can identify the set of differentially-methylated RNAs that may participate in tumor progression.
Further, single molecule base experiments can provide a more detailed regulatory role of specific RNA m5C.
View the full transcript and gain access to thousands of scientific videos
Overview
This research investigates the role of RNA methylation, specifically 5-methylcytosine, in pancreatic cancer. The study aims to elucidate how RNA methyltransferase regulation impacts cancer cell phenotypes, providing a detailed landscape of RNA m5C modifications.
Key Study Components
Research Area
- RNA methylation in cancer
- Pancreatic cancer
- Single-base resolution analysis
Background
- 5-methylcytosine modifications in RNA
- Impact on cancer cell differentiation
- Association with tumor progression
Methods Used
- Bisulfite RNA sequencing
- Experimental model in pancreatic cancer cells
- Standardized laboratory techniques
Main Results
- Identification of differentially-methylated RNAs involved in tumor progression
- Link between RNA m5C modification and poor differentiation
- Foundation for future studies on RNA methylation effects
Conclusions
- The study highlights the regulatory role of RNA m5C in pancreatic cancer
- It sets the stage for further research to differentiate between passenger and disease driver effects in RNA transcripts
Frequently Asked Questions
Executive Industry Relevance
Transcriptome-wide bisulfite-mRNA sequencing enables high-resolution mapping of 5-methylcytosine modifications, directly informing target validation and mechanistic de-risking in oncology discovery. This approach supports predictive confidence in linking RNA methylation patterns to disease phenotypes, facilitating risk-adjusted portfolio decisions at the early discovery and translational interface. Robust library preparation and quantitative methylation analysis are critical for reproducible, enterprise-scale biomarker and target assessment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of RNA methylation as a functional driver or passenger in disease models.
- Supports mechanistic de-risking by mapping m5C modifications at single-base resolution.
- Facilitates identification of RNA substrates linked to oncogenic phenotypes.
- Provides quantitative data for target confidence and triage in discovery portfolios.
Screening & Assay Development
- Delivers standardized, high-quality bisulfite-mRNA libraries for downstream sequencing workflows.
- Ensures reproducibility and comparability of methylation measurements across samples.
- Enables quantitative assessment of methylation changes in response to perturbations.
- Prepares validated systems for compound screening targeting RNA methyltransferases.
Translational & Preclinical Research
- Aligns methylation mapping with disease-relevant models, supporting translational biomarker discovery.
- Provides continuity from discovery through preclinical validation of RNA modification targets.
- Enables risk-adjusted advancement of candidate targets based on quantitative methylation profiles.
- Supports differentiation of driver versus passenger methylation events in tumor progression.
Pipeline & Workflow Integration
This bisulfite-mRNA library preparation protocol integrates into the discovery-to-preclinical continuum, supporting both hypothesis-driven target validation and translational biomarker alignment.
- Discovery Biology: Quantitative mapping of m5C modifications clarifies RNA regulatory pathways and disease mechanisms.
- Screening: Standardized library preparation ensures assay readiness and reproducibility for high-throughput sequencing.
- Analytics: Base-resolution methylation data enable robust statistical comparisons across experimental conditions.
- Translational Research: Methylation profiles inform biomarker strategies and preclinical model selection.
- Enterprise Reuse: The protocol supports scalable, reproducible workflows for diverse disease models and RNA targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in RNA modification-driven disease mechanisms.
- Operational Value: Standardizes library preparation and sequencing quality control for reproducible outputs.
- Strategic Value: Enables informed go/no-go decisions by linking methylation patterns to phenotypic outcomes.
- Portfolio Impact: Supports risk-adjusted prioritization of RNA modification targets in oncology and beyond.
Implementation Considerations
- Requires expertise in RNA handling, bisulfite chemistry, and sequencing library preparation.
- Demands access to high-quality total RNA and next-generation sequencing infrastructure.
- Necessitates rigorous quality control to ensure RNA integrity post-bisulfite conversion.
- Standardization across teams is essential for reproducibility and data comparability.
- Adaptation to other RNA species or disease models may require protocol optimization.
